Profile data is unavailable for this security.
About the company
cbdMD, Inc. is a consumer wellness company focused on the development, manufacturing, marketing, and sale of supplement brands powered by natural compounds. Its hemp-derived cannabinoids, include full-spectrum cannabidiol (CBD) formulations, hemp-derived Delta-9 THC products and a range of functional products designed to address key wellness needs, such as sleep, recovery, mood, discomfort, mobility, cognitive function, and stress management. It operates a multi-brand portfolio anchored by its flagship cbdMD line, which offers oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. Its Paw CBD pet-wellness brand provides tinctures, chews, and topicals for dogs and cats. Its ATRX platform offers non-cannabinoid functional ingredients such as functional mushrooms. Its Herbal Oasis (Oasis) brand is a premium hemp-derived THC-infused social seltzer that blends cannabinoids and nootropic mushrooms.
- Revenue in USD (TTM)19.19m
- Net income in USD-4.38m
- Incorporated2015
- Employees42.00
- LocationcbdMD Inc8845 Red Oak BlvdCHARLOTTE 28217-5593United StatesUSA
- Phone+1 (704) 445-3060
- Websitehttps://www.cbdmd.com/
More ▼
Mergers & acquisitions
| Acquired company | YCBD:ASQ since announced | Transaction value |
|---|---|---|
| Gaia Botanicals LLC | -34.47% | 1.02m |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sonoma Pharmaceuticals Inc | 17.72m | -3.37m | 4.76m | 168.00 | -- | 1.39 | -- | 0.2686 | -2.04 | -2.04 | 10.72 | 1.98 | 1.30 | 3.20 | 7.40 | 105,488.10 | -24.70 | -29.32 | -34.79 | -40.47 | 38.16 | 36.22 | -19.02 | -32.35 | 2.00 | -- | 0.00 | -- | 12.19 | -4.44 | 28.50 | -- | -17.24 | -- |
| LakeShore Biopharma Co Ltd | 89.02m | -14.47m | 5.33m | 573.00 | -- | 0.0371 | 0.801 | 0.0599 | -0.749 | -0.749 | 4.65 | 3.48 | 0.427 | 0.5001 | 1.30 | 155,360.70 | -6.94 | -- | -15.95 | -- | 82.47 | -- | -16.26 | -- | 0.7452 | -2.63 | 0.453 | -- | 7.24 | -- | 76.93 | -- | -- | -- |
| Sunshine Biopharma Inc | 37.32m | -5.99m | 5.74m | 52.00 | -- | 0.2204 | -- | 0.1538 | -2.03 | -2.03 | 10.74 | 5.31 | 1.21 | 2.09 | 10.12 | 717,764.30 | -19.47 | -68.65 | -23.80 | -89.02 | 33.01 | 32.79 | -16.06 | -81.12 | 2.09 | -209.95 | 0.00 | -- | 44.75 | 340.11 | -13.94 | -- | 370.33 | -- |
| cbdMD Inc | 19.19m | -4.38m | 7.36m | 42.00 | -- | 0.8655 | -- | 0.3835 | -3.92 | -3.92 | 4.77 | 0.8104 | 1.83 | 2.83 | 18.96 | -- | -19.44 | -48.27 | -44.42 | -54.99 | 62.37 | 63.95 | -10.63 | -85.60 | 1.20 | -- | 0.00 | -- | -1.50 | -14.45 | 43.21 | -- | -32.56 | -- |
| Tian'an Pharmaceutical Co Ltd | 10.65m | 3.14m | 8.00m | -- | 0.0445 | 0.0097 | 2.20 | 0.7511 | 0.2246 | 0.2246 | 0.7611 | 1.03 | -- | -- | -- | -- | -- | -- | -- | -- | 68.54 | -- | 29.51 | -- | 13.36 | 25.66 | 0.00 | -- | 50.51 | -- | 106.71 | -- | -- | -- |
| Gelteq Ltd | 117.16k | -4.70m | 8.52m | 7.00 | -- | 0.7618 | -- | 72.68 | -0.498 | -0.498 | 0.0124 | 1.04 | 0.0078 | -- | 0.5155 | 16,737.72 | -31.47 | -17.38 | -40.60 | -19.16 | -- | -- | -4,011.74 | -4,507.46 | -- | -3.52 | 0.2106 | -- | -- | -- | -87.40 | -- | -- | -- |
| Biofrontera Inc | 37.17m | -17.57m | 9.07m | 92.00 | -- | -- | -- | 0.2441 | -1.84 | -1.84 | 4.07 | -0.2216 | 2.19 | 2.44 | 9.45 | 403,967.40 | -103.57 | -48.03 | -339.69 | -77.55 | 64.41 | 48.93 | -47.28 | -60.99 | 0.8033 | -47.48 | 2.37 | -- | 9.54 | 7.35 | 11.78 | -- | -35.51 | -- |
| Cuprina Holdings (Cayman) Ltd | 24.05k | -2.25m | 9.22m | 14.00 | -- | 1.52 | -- | 383.54 | -0.1235 | -0.1235 | 0.0013 | 0.2837 | 0.0049 | 13.39 | 0.7976 | 1,717.75 | -44.56 | -- | -131.50 | -- | -69.27 | -- | -9,194.46 | -- | 3.58 | -306.25 | 0.0244 | -- | -52.05 | -- | -39.39 | -- | -- | -- |
| Integrated Biopharma Inc | 53.43m | 672.00k | 9.31m | 153.00 | 14.14 | 0.4543 | 9.40 | 0.1742 | 0.0212 | 0.0212 | 1.71 | 0.6597 | 2.07 | 4.45 | 12.77 | 349,183.00 | 2.60 | 9.98 | 3.28 | 13.68 | 9.75 | 10.74 | 1.26 | 4.58 | 1.92 | -- | 0.0072 | -- | 8.02 | 0.5933 | 482.30 | -30.67 | -0.8556 | -- |
| CV Sciences Inc | 14.37m | -1.48m | 9.37m | 47.00 | -- | 6.09 | -- | 0.6525 | -0.008 | -0.008 | 0.078 | 0.0084 | 1.87 | 1.67 | 34.74 | 305,659.60 | -19.21 | -44.92 | -66.32 | -105.32 | 47.04 | 42.89 | -10.29 | -49.08 | 0.2125 | -2.02 | 0.3829 | -- | -1.87 | -21.80 | -177.18 | -- | -56.43 | -- |
| Lotus Pharmaceuticals Inc | 70.79m | 1.72m | 9.52m | 233.00 | 0.0651 | 0.001 | 2.47 | 0.1345 | 0.0553 | 0.0553 | 2.56 | 3.58 | 0.6321 | 37.27 | 17.85 | 303,836.90 | 1.55 | 22.84 | 1.71 | 26.40 | 35.10 | 41.62 | 2.45 | 19.93 | 0.4428 | 30.80 | 0.0516 | 0.00 | 28.71 | 31.70 | -12.22 | 51.11 | 70.48 | -- |
| Bon Natural Life Ltd | 18.67m | -1.99m | 10.12m | 96.00 | 18.63 | 0.2316 | -- | 0.5418 | 0.088 | 0.088 | 6.74 | 7.08 | 0.2541 | 6.07 | 1.64 | 194,486.40 | -2.79 | 5.82 | -3.97 | 7.86 | 20.77 | 28.53 | -10.98 | 10.83 | 1.61 | -4.44 | 0.1735 | 0.00 | -21.70 | 0.4899 | -577.58 | -- | 18.20 | -- |
Data as of Feb 13 2026. Currency figures normalised to cbdMD Inc's reporting currency: US Dollar USD
4.92%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| CSS LLCas of 30 Sep 2025 | 142.62k | 1.36% |
| Chapin Davis, Inc. (Investment Management)as of 31 Dec 2025 | 81.25k | 0.77% |
| Alesco Advisors LLCas of 31 Dec 2025 | 68.51k | 0.65% |
| Jane Street Capital LLCas of 31 Dec 2025 | 51.14k | 0.49% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 51.05k | 0.49% |
| Vanguard Fiduciary Trust Co.as of 31 Dec 2025 | 47.16k | 0.45% |
| Citigroup Global Markets, Inc. (Investment Management)as of 31 Dec 2025 | 31.40k | 0.30% |
| Commonwealth Equity Services LLCas of 31 Dec 2025 | 16.26k | 0.16% |
| Scientech Research LLCas of 30 Sep 2025 | 15.41k | 0.15% |
| StoneX Group, Inc. (Investment Management)as of 31 Dec 2025 | 11.38k | 0.11% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
